I tumori cutanei maligni di interesse ORL - Luigi D'Ottavi - AOOI

6.
.
.
9.
60.
61.
62.
63.
64.
6 .
66.
6 .
6 .
69.
0.
1.
2.
3.
4.
.
6.
.
Mikolyzk DK.,Bednar MS.,Merkell cell tumourof the and:report of two cases.JAnd Srg
200 ;33A:404-06.
Murad Alam, M.D., and Desiree Ratner, M.D. Cutaneous Squamous-Cell Carcinoma
The New England Journal of Medicine Volume 344:9 -9 3 March 29, 2001.
Cauchi C., Visca P., Donati P., Lopez M. Tumori degli annessi cutanei. Clinica terapeutica
1 :44, 363-3 6, Universo, 2006.
Di Giovanni Giordano LanzaG.G. Istopatologia dei tumori. 4-90 Testo-atlante Pubblicato
da Piccin, 19 0.
Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for
Fox-Fordyce disease. J Am Acad Dermatol 2003; 4 : 4 3- .
Scrivener Y, Cribier B. Morphologie des glandes sudorales. Morphologie 2002; 6: -1 .
Mckee PH. Tumors of the epidermal appendages. En: Mckee PH, editor. Pathology of
the skin. Londres: Mosby-Wolfe; 1996. p. 1 . 1- 4.
Requena L, Kiryu H., Ackerman AB. Tubular adenoma. En: Neoplasms with apocrine
differentiation. 1.ª ed. Filadelfia: JB Lippincott-Raven; 199 . p.163.
Stout AP, Cooley SG. Carcinoma of sweat glands. Cancer 19 1; 4: 21- 36.
Urso C, Bondi R,Paglierani M, et al. Carcinoma of sweat glands. Report of 60 cases.
Arch Pathol Lab Med 2001.
Berg JW, McDivitt RW. Pathology of sweat gland carcinoma. Pathol Annu 196 ;3:
123-144.
Lever WF, Schaumburg-Lever G. Histopatholgy of the skin. JB Lippincott, Philadelphia,
19 3.
Abenoza P, Ackerman AB. Neoplasms with eccrine differentiation. Philadelphia and
London: Lea & Febiger 1990.
Neil D Gross, MD, Marcus Monroe, MD, Skin Cancer: Squamous Cell Carcinoma
Otolaryngology and plastic facial surgeryDec 22, 2006.
Boonchai W, Green A, Ng J, Dicker A, Chenevix-Trench G. Basal cell carcinoma
in chronic arsenicism in Queensland after ingestion of anasthma medication. J Am
Acad Dermatol 2000; In press.
Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, et al.
Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For
The Skin CancerPrevention Study Group. J NatlCancer Inst 1996; :1 4 –1 3.
Ewing MR. The significance of a single injury in the causation of basal cellcarcinoma
of the skin. Aust N Z J Surg 19 1; 41:140–14.
Bellomi M,Preda L, La valutazione della risposta alla terapia delle lesioni neoplastiche
Radiol. Med. 10 :4 0-4 ,2004 edizioni Minerva Medica TorinoAugust 200 .
O‘Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance
of clinical stage, extent of surgery and pathological findings in metastatic cutaneous
squamous carcinoma of thè parotid gland. Head Neck 2002; 24:41 -22.
Veness MJ, Palme CE~ Morgan GJ. High-risk cutaneous squamous ceiT carcinoma
of thè head and neck: results from 266 treated patients with metastatic lymph node
disease. Cancer 2006; 106:23 9-.
Kaufmann R, Spelman L, Weightman W, et al. Actinic Keratosis J Am Acad Dermatol.
Jan 200 ; 6(1):12 -43.
Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis,
and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications
for treatment modality selection. J Am Acad Dermatol 1992; 26:9 6–90.
4